Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2025-08-12 Governance Information
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关联交易管理制度
Governance Information Classification · 95% confidence The document is titled "关联交易管理制度" which translates to "Related Party Transaction Management System." It is a detailed policy document outlining the principles, definitions, procedures, and governance related to related party transactions within the company. It includes sections on the scope of related parties, decision-making authority, disclosure obligations, and avoidance of conflicts of interest. The document is issued by the company's board and dated August 13, 2025. There is no indication that this is a financial report, audit report, or announcement of voting results. It is a governance-related document detailing internal rules and procedures for managing related party transactions, which falls under governance information. The document length (6782 characters) and content confirm it is the actual policy document, not just an announcement or summary.
2025-08-12 Chinese
股东会议事规则
Governance Information Classification · 100% confidence The document is titled "股东会议事规则" which translates to "Shareholders Meeting Rules". It details the procedures, rules, and regulations governing the convening, proposal submission, notification, and conduct of shareholders' meetings for 宁波新芝生物科技股份有限公司. It includes sections on the general principles, convening of meetings, proposals and notifications, meeting conduct, supervision, and supplementary provisions. The document is a governance-related document outlining internal rules and procedures for shareholder meetings rather than a report of financial results, voting results, or announcements of meetings. It does not contain financial data, voting results, or announcements of report publications. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-12 Chinese
独立董事工作制度
Governance Information Classification · 95% confidence The document is titled '独立董事工作制度' which translates to 'Independent Director Work System'. It details the governance structure, qualifications, duties, nomination, election, and responsibilities of independent directors within the company. It references relevant laws, regulatory bodies such as the China Securities Regulatory Commission (中国证监会) and Beijing Stock Exchange (北京证券交易所), and company bylaws. The content is a detailed governance policy document rather than an announcement, report, or financial statement. It does not contain financial data, earnings, voting results, or management changes. It is a governance-related document outlining internal rules and practices for independent directors. Therefore, it fits best under the category 'Governance Information' (CGR). The document length (10,380 characters) and detailed content confirm it is the policy itself, not a brief announcement or certification.
2025-08-12 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '宁波新芝生物科技股份有限公司 对外担保管理制度' which translates to 'Ningbo New Gene Bio-tech Co., Ltd. External Guarantee Management System'. It details the company's internal policy and procedures regarding external guarantees, including approval processes, responsibilities, and risk management. The document includes references to board meetings and shareholder meetings approving the policy, but it is not a financial report, earnings release, or regulatory filing about financial results. It is a governance-related document outlining internal rules and management practices for external guarantees. There is no indication that this is an announcement of a report or a certification. Therefore, the document fits best under Governance Information (CGR). The document length (6197 characters) and detailed content support this classification with high confidence.
2025-08-12 Chinese
内部审计制度
Audit Report / Information Classification · 95% confidence The document is titled '内部审计制度' (Internal Audit System) and details the internal audit policies, responsibilities, organizational structure, and procedures of the company Ningbo Xinzhi Biotechnology Co., Ltd. It includes sections on audit committee roles, internal audit department duties, audit implementation, supervision, and information disclosure related to internal controls and audit processes. The document is a formal policy or system document approved by the board, not a standalone audit report or financial statement. It does not contain financial data or audit results but rather the framework and rules governing internal audit activities. This fits the category of Audit Report / Information (AR), which includes applied accounting principles and internal audit information but excludes full annual reports. The document is not an announcement or a brief notice, so it is not RPA or RNS. It is not a management report or governance report but specifically about internal audit procedures and policies. FY 2025
2025-08-12 Chinese
重大信息内部报告制度
Governance Information Classification · 95% confidence The document is titled as a "重大信息内部报告制度" which translates to "Major Information Internal Reporting System". It is a detailed internal governance document outlining the procedures, responsibilities, and scope for reporting major information within the company. It includes sections on the scope of major information, reporting obligations, procedures, management, and responsibilities. There is no financial data, earnings information, or audit results presented. It is not an announcement of a report but a governance policy document. The content aligns with internal governance and compliance rules rather than financial reporting or announcements. Therefore, the most appropriate classification is Governance Information (CGR).
2025-08-12 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.